Open Access
Review
Issue
SICOT-J
Volume 5, 2019
Article Number 40
Number of page(s) 6
Section Hip
DOI https://doi.org/10.1051/sicotj/2019037
Published online 04 November 2019
  1. Scaglione S, Kliethermes S, Cao G, et al. (2015) The epidemiology of cirrhosis in the United States: A population-based study. J Clin Gastroenterol 49(8), 690–696. [Google Scholar]
  2. Goral V, Simsek M, Mete N (2010) Hepatic osteodystrophy and liver cirrhosis. World J Gastroenterol 16(13), 1639–1643. [CrossRef] [PubMed] [Google Scholar]
  3. Handzlik-Orlik G, Holecki M, Wilczyński K, et al. (2016) Osteoporosis in liver disease: Pathogenesis and management. Ther Adv Endocrinol Metab 7(3), 128–135. [Google Scholar]
  4. Luxon B (2011) Bone disorders in chronic liver diseases. Curr Gastroenterol Rep 13, 40–48. [CrossRef] [PubMed] [Google Scholar]
  5. Dorr LD, Faugere MC, Mackel AM, et al. (1993) Structural and cellular assessment of bone quality of proximal femur. Bone 14(3), 231–242. [CrossRef] [PubMed] [Google Scholar]
  6. Thien TM, Chatziagorou G, Garellick G, et al. (2014) Periprosthetic femoral fracture within two years after total hip replacement: Analysis of 437,629 operations in the nordic arthroplasty register association database. J Bone Jt Surg Am 96(19), e167. [CrossRef] [Google Scholar]
  7. Carli AV, Negus JJ, Haddad FS (2017) Periprosthetic femoral fractures and trying to avoid them: What is the contribution of femoral component design to the increased risk of periprosthetic femoral fracture? Bone Joint J 99-B(1 Supple A), 50–59. [Google Scholar]
  8. Sukeik M, Alshryda S, Haddad FS, et al. (2011) Systematic review and meta-analysis of the use of tranexamic acid in total hip replacement. J Bone Joint Surg Br 93(1), 39–46. [CrossRef] [PubMed] [Google Scholar]
  9. Hailer NP, Garellick G, Kärrholm J (2010) Uncemented and cemented primary total hip arthroplasty in the Swedish Hip Arthroplasty Register. Acta Orthop 81(1), 34–41. [PubMed] [Google Scholar]
  10. Ziser A, Plevak DJ, Wiesner RH, et al. (1999) Morbidity and mortality in cirrhotic patients undergoing anesthesia and surgery. Anesthesiology 90(1), 42–53. [CrossRef] [PubMed] [Google Scholar]
  11. Cohen SM, Te HS, Levitsky J (2005) Operative risk of total hip and knee arthroplasty in cirrhotic patients. J Arthroplast 20(4), 460–466. [CrossRef] [Google Scholar]
  12. Hsieh PH, Chen LH, Lee MS, et al. (2003) Hip arthroplasty in patients with cirrhosis of the liver. J Bone Joint Surg Br 85(6), 818–821. [CrossRef] [PubMed] [Google Scholar]
  13. Jiang SL, Schairer WW, Bozic KJ (2014) Increased rates of periprosthetic joint infection in patients with cirrhosis undergoing total joint arthroplasty. Clin Orthop Relat Res 472(8), 2483–2491. [CrossRef] [PubMed] [Google Scholar]
  14. Moon Y-W, Kim Y-S, Kwon S-Y, Kim S-Y, Lim S-J, Park Y-S (2007) Perioperative risk of hip arthroplasty in patients with cirrhotic liver disease. J Korean Med Sci 22(2), 223–226. [CrossRef] [PubMed] [Google Scholar]
  15. Newman JM, Schiltz NK, Mudd CD, et al. (2016) Impact of cirrhosis on resource use and inpatient complications in patients undergoing total knee and hip arthroplasty. J Arthroplast 31(11), 2395–2401. [CrossRef] [Google Scholar]
  16. Orozco F, Post Z, Baxi O, et al. (2014) Fibrosis in hepatitis C patients predicts complications after elective total joint arthroplasty. J Arthroplast 29, 7–10. [Google Scholar]
  17. Pour A, Matar W, Jafari M, et al. (2011) Total joint arthroplasty in patients with hepatitis C. J Bone Joint Surg Am 15, 1448–1454. [Google Scholar]
  18. Seol YJ, Yoon TR, Lee DH, et al. (2017) Outcome analysis of hip or knee arthroplasty in patients with cirrhotic liver disease. J Orthop 14(1), 171–175. [PubMed] [Google Scholar]
  19. Aminata I, Lee SH, Chang JS, et al. (2012) Perioperative morbidity and mortality of total hip replacement in liver transplant recipients: A 7-year single-center experience. Transplantation 94(11), 1154–1159. [CrossRef] [PubMed] [Google Scholar]
  20. Ledford CK, Watters TS, Wellman SS, et al. (2014) Risk versus reward: Total joint arthroplasty outcomes after various solid organ transplantations. J Arthroplast 29(8), 1548–1552. [CrossRef] [Google Scholar]
  21. Levitsky J, Te HS, Cohen SM (2003) The safety and outcome of joint replacement surgery in liver transplant recipients. Liver Transpl 9(4), 373–376. [CrossRef] [PubMed] [Google Scholar]
  22. Cavanaugh PK, Chen AF, Rasouli MR, et al. (2015) Total joint arthroplasty in transplant recipients: In-hospital adverse outcomes. J Arthroplast 30(5), 840–845. [CrossRef] [Google Scholar]
  23. Deleuran T, Vilstrup H, Overgaard S, et al. (2015) Cirrhosis patients have increased risk of complications after hip or knee arthroplasty. Acta Orthop 86(1), 108–113. [PubMed] [Google Scholar]
  24. Tiberi JV, Hansen V, El-Abbadi N, et al. (2014) Increased complication rates after hip and knee arthroplasty in patients with cirrhosis of the liver. Clin Orthop Relat Res 472(9), 2774–2778. [CrossRef] [PubMed] [Google Scholar]
  25. Poultsides LA, Ma Y, Della Valle AG, et al. (2013) In-hospital surgical site infections after primary hip and knee arthroplasty – Incidence and risk factors. J Arthroplast 28(3), 385–389. [CrossRef] [Google Scholar]
  26. Patel T (1999) Surgery in the patient with liver disease. Mayo Clin Proc 74(6), 593–599. [CrossRef] [PubMed] [Google Scholar]
  27. Goodnough LT, Maniatis A, Earnshaw P, et al. (2011) Detection, evaluation and management of preoperative anaemia in the elective orthopaedic surgical patient: NATA guidelines. Br J Anaesth 106(1), 13–22. [CrossRef] [PubMed] [Google Scholar]
  28. Sköldenberg OG, Salemyr MO, Bodén HS, et al. (2011) The effect of weekly risedronate on periprosthetic bone resorption following total hip arthroplasty: A randomized, double-blind, placebo-controlled trial. J Bone Jt Surg Am 93(20), 1857–1864. [CrossRef] [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.